Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma
- PMID: 16856963
- DOI: 10.1111/j.1600-0463.2006.apm_323.x
Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma
Abstract
Gene product expression in normal and chronic hepatitis C virus infection was determined in an attempt to improve our understanding of the molecular events leading to the development of cirrhosis and liver carcinoma. Activation of CD95 (Fas) causes apoptosis of cells and liver failure in mice and has been associated with human liver disorders. c-myc is involved in cell proliferation and EGFR in regeneration of cells. The material of the current study included 50 cases of chronic hepatitis C (CHC) (and negative hepatitis B virus infection), 29 cases of liver cirrhosis and HCV (LC), and 19 cases of hepatocellular carcinoma and HCV (HCC) admitted to the Theodor Bilharz Research Institute (TBRI) during the years 2003-2004. Ten wedge liver biopsies - taken during laparoscopic cholecystectomy - were included in the study as normal controls. Laboratory investigations, including liver function tests, serological markers for viral hepatitis and serum alpha fetoprotein level (alpha-FP), were determined for all cases. Histopathological study and immunohistochemistry using monoclonal antibodies for CD95, c-myc and EGFR were also done. In CHC cases, the histological activity index (HAI) revealed more expression of Fas antigen in liver tissues with active inflammation than in those without active inflammation (p < 0.01). EGFR and c-myc act synergistically in liver tumorigenesis. Upregulation of Fas in chronic hepatitis C infection and of c-myc & EGFR in malignant transformation was concluded from this study. c-myc expression may obstruct the induction of apoptosis of HCC cells and lead to uncontrolled cell growth.
Similar articles
-
The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.J Clin Virol. 2005 Oct;34(2):140-6. doi: 10.1016/j.jcv.2005.02.012. J Clin Virol. 2005. PMID: 16157266
-
Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.Hepatogastroenterology. 1993 Feb;40(1):37-40. Hepatogastroenterology. 1993. PMID: 8462926
-
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x. J Viral Hepat. 2005. PMID: 16255765
-
Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.APMIS. 2015 Oct;123(10):823-31. doi: 10.1111/apm.12431. Epub 2015 Aug 17. APMIS. 2015. PMID: 26279457 Review.
-
Viral hepatitis and liver cancer: the case of hepatitis C.Oncogene. 2006 Jun 26;25(27):3834-47. doi: 10.1038/sj.onc.1209562. Oncogene. 2006. PMID: 16799625 Review.
Cited by
-
Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.Medscape J Med. 2008 Jun 3;10(6):130. Medscape J Med. 2008. PMID: 18679533 Free PMC article.
-
Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.J Virol. 2012 Oct;86(20):10935-49. doi: 10.1128/JVI.00750-12. Epub 2012 Aug 1. J Virol. 2012. PMID: 22855500 Free PMC article.
-
Calcium Regulates HCC Proliferation as well as EGFR Recycling/Degradation and Could Be a New Therapeutic Target in HCC.Cancers (Basel). 2019 Oct 18;11(10):1588. doi: 10.3390/cancers11101588. Cancers (Basel). 2019. PMID: 31635301 Free PMC article.
-
The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma.Hepat Mon. 2012 Oct;12(10 HCC):e7492. doi: 10.5812/hepatmon.7492. Epub 2012 Oct 11. Hepat Mon. 2012. PMID: 23162604 Free PMC article.
-
Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor-MIG6 Axis.Cancers (Basel). 2021 Mar 25;13(7):1515. doi: 10.3390/cancers13071515. Cancers (Basel). 2021. PMID: 33806040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous